Protocol No.: MORAb-003-009; A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination with a Platinum Containing Doublet in Chemotherapy-NaiveSubjects with Stage IV Adenocarcinoma of the Lung

  • Willis, Maurice, (PI)

Project: Other project

StatusFinished
Effective start/end date7/27/117/31/14

Funding

  • Morphotek Incorporated: $20,535.00